| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase UNSPECIFIED ION MODE | 21 | APOE genotype:e2/e2 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 34 | APOE genotype:e2/e2 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 2 | APOE genotype:e2/e3 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 32 | APOE genotype:e2/e3 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 35 | APOE genotype:e2/e3 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 46 | APOE genotype:e2/e3 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 60 | APOE genotype:e2/e3 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 69 | APOE genotype:e2/e3 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 80 | APOE genotype:e2/e3 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 29 | APOE genotype:e2/e3 | TMEM SNP:G/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 9 | APOE genotype:e2/e3 | TMEM SNP:G/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 59 | APOE genotype:e2/e3 | TMEM SNP:NA | % Total |
| Reversed phase UNSPECIFIED ION MODE | 45 | APOE genotype:e2/e4 | TMEM SNP:A/A | % Total |
| Reversed phase UNSPECIFIED ION MODE | 8 | APOE genotype:e2/e4 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 53 | APOE genotype:e2/e4 | TMEM SNP:G/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 61 | APOE genotype:e2/e4 | TMEM SNP:G/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 13 | APOE genotype:e3/e3 | TMEM SNP:A/A | % Total |
| Reversed phase UNSPECIFIED ION MODE | 16 | APOE genotype:e3/e3 | TMEM SNP:A/A | % Total |
| Reversed phase UNSPECIFIED ION MODE | 18 | APOE genotype:e3/e3 | TMEM SNP:A/A | % Total |
| Reversed phase UNSPECIFIED ION MODE | 22 | APOE genotype:e3/e3 | TMEM SNP:A/A | % Total |
| Reversed phase UNSPECIFIED ION MODE | 30 | APOE genotype:e3/e3 | TMEM SNP:A/A | % Total |
| Reversed phase UNSPECIFIED ION MODE | 33 | APOE genotype:e3/e3 | TMEM SNP:A/A | % Total |
| Reversed phase UNSPECIFIED ION MODE | 36 | APOE genotype:e3/e3 | TMEM SNP:A/A | % Total |
| Reversed phase UNSPECIFIED ION MODE | 37 | APOE genotype:e3/e3 | TMEM SNP:A/A | % Total |
| Reversed phase UNSPECIFIED ION MODE | 50 | APOE genotype:e3/e3 | TMEM SNP:A/A | % Total |
| Reversed phase UNSPECIFIED ION MODE | 56 | APOE genotype:e3/e3 | TMEM SNP:A/A | % Total |
| Reversed phase UNSPECIFIED ION MODE | 62 | APOE genotype:e3/e3 | TMEM SNP:A/A | % Total |
| Reversed phase UNSPECIFIED ION MODE | 67 | APOE genotype:e3/e3 | TMEM SNP:A/A | % Total |
| Reversed phase UNSPECIFIED ION MODE | 71 | APOE genotype:e3/e3 | TMEM SNP:A/A | % Total |
| Reversed phase UNSPECIFIED ION MODE | 75 | APOE genotype:e3/e3 | TMEM SNP:A/A | % Total |
| Reversed phase UNSPECIFIED ION MODE | 76 | APOE genotype:e3/e3 | TMEM SNP:A/A | % Total |
| Reversed phase UNSPECIFIED ION MODE | 12 | APOE genotype:e3/e3 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 19 | APOE genotype:e3/e3 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 27 | APOE genotype:e3/e3 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 38 | APOE genotype:e3/e3 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 41 | APOE genotype:e3/e3 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 42 | APOE genotype:e3/e3 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 44 | APOE genotype:e3/e3 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 47 | APOE genotype:e3/e3 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 48 | APOE genotype:e3/e3 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 5 | APOE genotype:e3/e3 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 51 | APOE genotype:e3/e3 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 52 | APOE genotype:e3/e3 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 55 | APOE genotype:e3/e3 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 58 | APOE genotype:e3/e3 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 6 | APOE genotype:e3/e3 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 64 | APOE genotype:e3/e3 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 68 | APOE genotype:e3/e3 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 7 | APOE genotype:e3/e3 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 73 | APOE genotype:e3/e3 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 74 | APOE genotype:e3/e3 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 78 | APOE genotype:e3/e3 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 10 | APOE genotype:e3/e3 | TMEM SNP:G/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 11 | APOE genotype:e3/e3 | TMEM SNP:G/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 15 | APOE genotype:e3/e3 | TMEM SNP:G/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 17 | APOE genotype:e3/e3 | TMEM SNP:G/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 20 | APOE genotype:e3/e3 | TMEM SNP:G/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 24 | APOE genotype:e3/e3 | TMEM SNP:G/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 26 | APOE genotype:e3/e3 | TMEM SNP:G/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 57 | APOE genotype:e3/e3 | TMEM SNP:G/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 66 | APOE genotype:e3/e3 | TMEM SNP:G/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 79 | APOE genotype:e3/e3 | TMEM SNP:G/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 31 | APOE genotype:e3/e3 | TMEM SNP:NA | % Total |
| Reversed phase UNSPECIFIED ION MODE | 77 | APOE genotype:e3/e3 | TMEM SNP:NA | % Total |
| Reversed phase UNSPECIFIED ION MODE | 1 | APOE genotype:e3/e4 | TMEM SNP:A/A | % Total |
| Reversed phase UNSPECIFIED ION MODE | 23 | APOE genotype:e3/e4 | TMEM SNP:A/A | % Total |
| Reversed phase UNSPECIFIED ION MODE | 70 | APOE genotype:e3/e4 | TMEM SNP:A/A | % Total |
| Reversed phase UNSPECIFIED ION MODE | 14 | APOE genotype:e3/e4 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 25 | APOE genotype:e3/e4 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 39 | APOE genotype:e3/e4 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 49 | APOE genotype:e3/e4 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 54 | APOE genotype:e3/e4 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 63 | APOE genotype:e3/e4 | TMEM SNP:A/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 28 | APOE genotype:e3/e4 | TMEM SNP:G/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 43 | APOE genotype:e3/e4 | TMEM SNP:G/G | % Total |
| Reversed phase UNSPECIFIED ION MODE | 65 | APOE genotype:e3/e4 | TMEM SNP:G/G | % Total |
Return to study ST002928 main page
Download data matrix(The major TMEM106B dementia risk allele affects TMEM106B protein levels, fibril formation, and myelin lipid homeostasis in the ageing human hippocampus Reversed phase UNSPECIFIED ION MODE)
- Metabolomics Workbench
|